GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $883,000 | +10.1% | 22,600 | 0.0% | 0.36% | +14.1% |
| Q4 2017 | $802,000 | -12.6% | 22,600 | 0.0% | 0.32% | -18.6% |
| Q3 2017 | $918,000 | -5.8% | 22,600 | 0.0% | 0.39% | -3.7% |
| Q2 2017 | $975,000 | +2.3% | 22,600 | 0.0% | 0.41% | -11.3% |
| Q1 2017 | $953,000 | +9.5% | 22,600 | 0.0% | 0.46% | +4.8% |
| Q4 2016 | $870,000 | -10.8% | 22,600 | 0.0% | 0.44% | -12.9% |
| Q3 2016 | $975,000 | -99.9% | 22,600 | 0.0% | 0.50% | +122.6% |
| Q2 2016 | $979,484,000 | +6.9% | 22,600 | 0.0% | 0.23% | -7.4% |
| Q1 2016 | $916,430,000 | +0.5% | 22,600 | 0.0% | 0.24% | -2.4% |
| Q4 2015 | $911,910,000 | +4.9% | 22,600 | 0.0% | 0.25% | -0.4% |
| Q3 2015 | $868,970,000 | -7.7% | 22,600 | 0.0% | 0.25% | +28.7% |
| Q2 2015 | $941,290,000 | -9.8% | 22,600 | 0.0% | 0.20% | -13.3% |
| Q1 2015 | $1,042,990,000 | +13.5% | 22,600 | +5.1% | 0.22% | +3.7% |
| Q4 2014 | $918,910,000 | – | 21,500 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
| Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
| KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
| EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
| JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
| Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
| NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
| Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
| CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
| Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |